219 related articles for article (PubMed ID: 26543233)
41. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
43. Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer.
Zhao R; Chen G
Int J Clin Exp Pathol; 2015; 8(11):14909-16. PubMed ID: 26823821
[TBL] [Abstract][Full Text] [Related]
44. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
[TBL] [Abstract][Full Text] [Related]
45. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
[TBL] [Abstract][Full Text] [Related]
46. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
[TBL] [Abstract][Full Text] [Related]
47. Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.
Wu S; Shen W; Yang L; Zhu M; Zhang M; Zong F; Geng L; Wang Y; Huang T; Pan Y; Cao S; Dai J; Ma H; Wu J
Cancer Med; 2019 May; 8(5):2636-2645. PubMed ID: 30843663
[TBL] [Abstract][Full Text] [Related]
48. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
49. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
Guo H; Bai Y; Xu P; Hu Z; Liu L; Wang F; Jin G; Wang F; Deng Q; Tu Y; Feng M; Lu D; Shen H; Wu T
J Clin Oncol; 2010 Apr; 28(11):1928-35. PubMed ID: 20231684
[TBL] [Abstract][Full Text] [Related]
50. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
52. Genetic Variations in Key MicroRNAs are Associated With the Survival of Nonsmall Cell Lung Cancer.
Wu S; Shen W; Pan Y; Zhu M; Xie K; Geng L; Wang Y; Liang Y; Xu J; Cao S; Xu W; Chen B; Hu Z; Ma H; Wu J; Shen H
Medicine (Baltimore); 2015 Nov; 94(47):e2084. PubMed ID: 26632718
[TBL] [Abstract][Full Text] [Related]
53. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
[TBL] [Abstract][Full Text] [Related]
54. Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival.
Kong J; Xu F; Qu J; Wang Y; Gao M; Yu H; Qian B
Oncotarget; 2015 Feb; 6(4):2573-82. PubMed ID: 25544771
[TBL] [Abstract][Full Text] [Related]
55. Rs895819 within miR-27a might be involved in development of non small cell lung cancer in the Chinese Han population.
Ma JY; Yan HJ; Yang ZH; Gu W
Asian Pac J Cancer Prev; 2015; 16(5):1939-44. PubMed ID: 25773791
[TBL] [Abstract][Full Text] [Related]
56. Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis.
Liu Y; Qing H; Su X; Wang C; Li Z; Liu S
Med Sci Monit; 2015 Sep; 21():2694-700. PubMed ID: 26356590
[TBL] [Abstract][Full Text] [Related]
57. KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.
Kong L; Zhang P; Li W; Yang Y; Tian Y; Wang X; Chen S; Yang Y; Huang T; Zhao T; Tang L; Su B; Li F; Liu XS; Zhang F
Oncotarget; 2016 May; 7(19):27959-74. PubMed ID: 27058897
[TBL] [Abstract][Full Text] [Related]
58. MiRNAs associated polymorphisms in the 3'UTR of MET promote the risk of non-small cell lung cancer.
Zhu X; Fu C; Zhang L; Xu G; Wang S
Cell Physiol Biochem; 2015; 37(3):1159-67. PubMed ID: 26402720
[TBL] [Abstract][Full Text] [Related]
59. ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.
Li Y; Ye Z; Chen S; Pan Z; Zhou Q; Li YZ; Shuai WD; Kuang CM; Peng QH; Shi W; Mao X; Liu RY; Huang W
Int J Cancer; 2018 Apr; 142(7):1379-1391. PubMed ID: 29164615
[TBL] [Abstract][Full Text] [Related]
60. DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.
Pan H; Chai W; Liu X; Yu T; Sun L; Yan M
Exp Cell Res; 2021 Dec; 409(1):112897. PubMed ID: 34717919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
